These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35584094)

  • 1. Factors affecting prolonged time to extubation in patients given remimazolam.
    Shimamoto Y; Sanuki M; Kurita S; Ueki M; Kuwahara Y; Matsumoto A
    PLoS One; 2022; 17(5):e0268568. PubMed ID: 35584094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J; Leonowens C; Ivaturi VD; Lohmer LL; Curd L; Ossig J; Schippers F; Petersen KU; Stoehr T; Schmith V
    J Clin Anesth; 2020 Nov; 66():109899. PubMed ID: 32585566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice.
    Masui K; Stöhr T; Pesic M; Tonai T
    J Anesth; 2022 Aug; 36(4):493-505. PubMed ID: 35708787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recall of extubation after remimazolam anesthesia with flumazenil antagonism during emergence: a retrospective clinical study.
    Sato T; Mimuro S; Kurita T; Kobayashi M; Doi M; Katoh T; Nakajima Y
    J Anesth; 2022 Dec; 36(6):688-692. PubMed ID: 36076100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial.
    Doi M; Morita K; Takeda J; Sakamoto A; Yamakage M; Suzuki T
    J Anesth; 2020 Aug; 34(4):543-553. PubMed ID: 32417976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial.
    Doi M; Hirata N; Suzuki T; Morisaki H; Morimatsu H; Sakamoto A
    J Anesth; 2020 Aug; 34(4):491-501. PubMed ID: 32303884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial.
    Liu M; Sun Y; Zhou L; Feng K; Wang T; Feng X
    Clin Interv Aging; 2022; 17():837-843. PubMed ID: 35620021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective dose and adverse reactions analysis of Remimazolam for sedation in elderly patients undergoing gastroscopy].
    Sun H; Wang T; Xu ZX; Chen XF; Cao JB; Li H
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(5):332-335. PubMed ID: 35092973
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups.
    Oh J; Park SY; Lee SY; Song JY; Lee GY; Park JH; Joe HB
    Korean J Anesthesiol; 2022 Dec; 75(6):510-517. PubMed ID: 35912426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.
    Dai G; Pei L; Duan F; Liao M; Zhang Y; Zhu M; Zhao Z; Zhang X
    Minerva Anestesiol; 2021 Oct; 87(10):1073-1079. PubMed ID: 34263581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibration rate constant, k
    Masui K; Hagihira S
    J Anesth; 2022 Dec; 36(6):757-762. PubMed ID: 36018387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of remimazolam after intravenous infusion in anaesthetised children.
    Gao YQ; Ihmsen H; Hu ZY; Sun W; Fang YB; Wang Z; Schüttler J; Jeleazcov C; Liu HC
    Br J Anaesth; 2023 Nov; 131(5):914-920. PubMed ID: 37739904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study.
    Chae D; Kim HC; Song Y; Choi YS; Han DW
    Br J Anaesth; 2022 Jul; 129(1):49-57. PubMed ID: 35562226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remimazolam anaphylaxis during anesthesia induction.
    Tsurumi K; Takahashi S; Hiramoto Y; Nagumo K; Takazawa T; Kamiyama Y
    J Anesth; 2021 Aug; 35(4):571-575. PubMed ID: 34050439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis: a prospective, observational pilot study.
    Nakanishi T; Sento Y; Kamimura Y; Tsuji T; Kako E; Sobue K
    BMC Anesthesiol; 2021 Dec; 21(1):306. PubMed ID: 34872518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction.
    Lu Z; Zhou N; Li Y; Yang L; Hao W
    Ann Palliat Med; 2022 Feb; 11(2):568-573. PubMed ID: 35249335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.